![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Myo1d | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Myo1d (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of MYO1D mRNA | CTD | PMID:22206623 | Myo1d | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Myo1d (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYO1D mRNA | CTD | PMID:22206623 | Myo1d | Rat | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | MYO1D (Homo sapiens) | 6480464 | Dinitrochlorobenzene binds to MYO1D protein | CTD | PMID:32991956 | Myo1d | Rat | 17beta-estradiol | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | Estradiol results in increased expression of MYO1D mRNA | CTD | PMID:15289156 | Myo1d | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Myo1d (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MYO1D mRNA | CTD | PMID:21570461 | Myo1d | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MYO1D mRNA | CTD | PMID:34747641 | Myo1d | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Myo1d (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MYO1D mRNA | CTD | PMID:33956508 | Myo1d | Rat | 2-butoxyethanol | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of MYO1D mRNA | CTD | PMID:19812364 | Myo1d | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Myo1d (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of MYO1D mRNA | CTD | PMID:26251327 | Myo1d | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MYO1D mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MYO1D mRNA | CTD | PMID:28628672 | Myo1d | Rat | 3-methylcholanthrene | decreases expression | ISO | Myo1d (Mus musculus) | 6480464 | Methylcholanthrene results in decreased expression of MYO1D mRNA | CTD | PMID:20713471 | Myo1d | Rat | 3-Nitrobenzanthrone | affects expression | ISO | MYO1D (Homo sapiens) | 6480464 | 3-nitrobenzanthrone affects the expression of MYO1D mRNA | CTD | PMID:34036453 | Myo1d | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | bisphenol S results in increased expression of MYO1D mRNA | CTD | PMID:30951980 | Myo1d | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | Fenretinide results in increased expression of MYO1D mRNA | CTD | PMID:28973697 | Myo1d | Rat | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of MYO1D mRNA | CTD | PMID:19483382 | Myo1d | Rat | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of MYO1D mRNA | CTD | PMID:19483382 | Myo1d | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of MYO1D mRNA | CTD | PMID:30047161 | Myo1d | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of MYO1D mRNA | CTD | PMID:24780913 more ... | Myo1d | Rat | acrolein | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of MYO1D mRNA | CTD | PMID:32845096 | Myo1d | Rat | aflatoxin B1 | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of MYO1D mRNA | CTD | PMID:21641981 more ... | Myo1d | Rat | aflatoxin B1 | increases methylation | ISO | MYO1D (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MYO1D 3' UTR and Aflatoxin B1 results in increased methylation of MYO1D intron | CTD | PMID:30157460 | Myo1d | Rat | all-trans-retinoic acid | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MYO1D mRNA | CTD | PMID:33167477 | Myo1d | Rat | amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of MYO1D mRNA | CTD | PMID:19483382 | Myo1d | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of MYO1D mRNA | CTD | PMID:30047161 | Myo1d | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MYO1D mRNA | CTD | PMID:16483693 | Myo1d | Rat | aristolochic acid A | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MYO1D mRNA | CTD | PMID:33212167 | Myo1d | Rat | arsane | affects methylation | ISO | MYO1D (Homo sapiens) | 6480464 | Arsenic affects the methylation of MYO1D gene | CTD | PMID:25304211 | Myo1d | Rat | arsenic atom | affects methylation | ISO | MYO1D (Homo sapiens) | 6480464 | Arsenic affects the methylation of MYO1D gene | CTD | PMID:25304211 | Myo1d | Rat | benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of MYO1D mRNA | CTD | PMID:19483382 | Myo1d | Rat | benzo[a]pyrene | decreases expression | ISO | Myo1d (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MYO1D mRNA | CTD | PMID:19770486 and PMID:21715664 | Myo1d | Rat | benzo[a]pyrene | increases methylation | ISO | MYO1D (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of MYO1D 3' UTR and Benzo(a)pyrene results in increased methylation of MYO1D promoter | CTD | PMID:27901495 | Myo1d | Rat | benzo[a]pyrene | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of MYO1D mRNA | CTD | PMID:20064835 more ... | Myo1d | Rat | benzo[a]pyrene | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MYO1D mRNA | CTD | PMID:22228805 | Myo1d | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | Myo1d | Rat | beta-lapachone | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of MYO1D mRNA | CTD | PMID:38218311 | Myo1d | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of MYO1D mRNA | CTD | PMID:31163220 | Myo1d | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of MYO1D mRNA | CTD | PMID:25181051 | Myo1d | Rat | bisphenol A | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | bisphenol A results in increased expression of MYO1D mRNA | CTD | PMID:32156529 | Myo1d | Rat | bisphenol A | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | bisphenol A results in increased expression of MYO1D protein | CTD | PMID:34186270 | Myo1d | Rat | bisphenol A | decreases methylation | ISO | MYO1D (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of MYO1D gene | CTD | PMID:31601247 | Myo1d | Rat | bisphenol A | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MYO1D gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MYO1D mRNA | CTD | PMID:28628672 and PMID:31601247 | Myo1d | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MYO1D gene | CTD | PMID:28505145 | Myo1d | Rat | Bisphenol B | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | bisphenol B results in increased expression of MYO1D protein | CTD | PMID:34186270 | Myo1d | Rat | bisphenol F | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MYO1D mRNA | CTD | PMID:28628672 | Myo1d | Rat | bisphenol F | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | bisphenol F results in increased expression of MYO1D protein | CTD | PMID:34186270 | Myo1d | Rat | bisphenol F | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | bisphenol F results in increased expression of MYO1D mRNA | CTD | PMID:30951980 | Myo1d | Rat | calcitriol | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of MYO1D mRNA | CTD | PMID:21592394 | Myo1d | Rat | calcitriol | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Calcitriol results in increased expression of MYO1D mRNA | CTD | PMID:16002434 and PMID:21592394 | Myo1d | Rat | CGP 52608 | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MYO1D gene] | CTD | PMID:28238834 | Myo1d | Rat | chlordecone | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | Chlordecone results in increased expression of MYO1D mRNA | CTD | PMID:29980752 | Myo1d | Rat | cisplatin | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of MYO1D mRNA | CTD | PMID:27392435 | Myo1d | Rat | cisplatin | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of MYO1D mRNA | CTD | PMID:27392435 | Myo1d | Rat | clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of MYO1D mRNA | CTD | PMID:19483382 | Myo1d | Rat | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of MYO1D mRNA | CTD | PMID:24386269 | Myo1d | Rat | cobalt dichloride | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of MYO1D mRNA | CTD | PMID:19320972 | Myo1d | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of MYO1D mRNA | CTD | PMID:26577399 and PMID:27523638 | Myo1d | Rat | cycloheximide | affects response to substance | ISO | MYO1D (Homo sapiens) | 6480464 | MYO1D gene SNP affects the susceptibility to Cycloheximide | CTD | PMID:25622337 | Myo1d | Rat | dexamethasone | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MYO1D mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MYO1D mRNA | CTD | PMID:28628672 | Myo1d | Rat | diethylstilbestrol | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of MYO1D mRNA | CTD | PMID:15289156 | Myo1d | Rat | dioxygen | multiple interactions | ISO | Myo1d (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of MYO1D mRNA | CTD | PMID:30529165 | Myo1d | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of MYO1D mRNA | CTD | PMID:21551480 | Myo1d | Rat | dorsomorphin | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Myo1d | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of MYO1D mRNA | CTD | PMID:29391264 | Myo1d | Rat | entinostat | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | entinostat results in increased expression of MYO1D mRNA | CTD | PMID:26272509 and PMID:27188386 | Myo1d | Rat | entinostat | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO1D mRNA | CTD | PMID:27188386 | Myo1d | Rat | ethanol | affects expression | ISO | Myo1d (Mus musculus) | 6480464 | Ethanol affects the expression of MYO1D mRNA | CTD | PMID:30319688 | Myo1d | Rat | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of MYO1D mRNA | CTD | PMID:18035473 | Myo1d | Rat | folic acid | multiple interactions | ISO | Myo1d (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYO1D mRNA | CTD | PMID:22206623 | Myo1d | Rat | formaldehyde | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of MYO1D mRNA | CTD | PMID:23649840 | Myo1d | Rat | fulvestrant | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MYO1D gene | CTD | PMID:31601247 | Myo1d | Rat | genistein | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | Genistein results in increased expression of MYO1D mRNA | CTD | PMID:15289156 | Myo1d | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MYO1D mRNA | CTD | PMID:33387578 | Myo1d | Rat | glafenine | decreases expression | EXP | | 6480464 | Glafenine results in decreased expression of MYO1D mRNA | CTD | PMID:24136188 | Myo1d | Rat | glycidol | decreases expression | EXP | | 6480464 | glycidol results in decreased expression of MYO1D mRNA | CTD | PMID:24395379 | Myo1d | Rat | indometacin | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MYO1D mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MYO1D mRNA | CTD | PMID:28628672 | Myo1d | Rat | inulin | multiple interactions | ISO | Myo1d (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MYO1D mRNA | CTD | PMID:36331819 | Myo1d | Rat | L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of MYO1D mRNA | CTD | PMID:19483382 | Myo1d | Rat | mercury dibromide | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of MYO1D mRNA | CTD | PMID:26272509 | Myo1d | Rat | mercury dibromide | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO1D mRNA | CTD | PMID:27188386 | Myo1d | Rat | methyl methanesulfonate | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of MYO1D mRNA | CTD | PMID:23649840 | Myo1d | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of MYO1D mRNA | CTD | PMID:24810058 | Myo1d | Rat | N-nitrosomorpholine | decreases expression | EXP | | 6480464 | N-nitrosomorpholine results in decreased expression of MYO1D protein | CTD | PMID:19716841 | Myo1d | Rat | nefazodone | decreases expression | EXP | | 6480464 | nefazodone results in decreased expression of MYO1D mRNA | CTD | PMID:24136188 | Myo1d | Rat | nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of MYO1D mRNA | CTD | PMID:24136188 | Myo1d | Rat | omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of MYO1D mRNA | CTD | PMID:19483382 | Myo1d | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MYO1D mRNA | CTD | PMID:25729387 | Myo1d | Rat | ozone | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of MYO1D mRNA | CTD | PMID:32845096 | Myo1d | Rat | panobinostat | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO1D mRNA | CTD | PMID:27188386 | Myo1d | Rat | panobinostat | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | panobinostat results in increased expression of MYO1D mRNA | CTD | PMID:26272509 | Myo1d | Rat | paracetamol | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of MYO1D mRNA | CTD | PMID:22230336 and PMID:29067470 | Myo1d | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Myo1d (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MYO1D mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MYO1D mRNA | CTD | PMID:36331819 | Myo1d | Rat | perfluorooctanoic acid | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of MYO1D mRNA | CTD | PMID:36326898 | Myo1d | Rat | phenobarbital | multiple interactions | ISO | Myo1d (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of MYO1D mRNA] | CTD | PMID:19482888 | Myo1d | Rat | phenobarbital | decreases expression | ISO | Myo1d (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of MYO1D mRNA | CTD | PMID:19482888 | Myo1d | Rat | phenylmercury acetate | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of MYO1D mRNA | CTD | PMID:26272509 | Myo1d | Rat | phenylmercury acetate | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO1D mRNA | CTD | PMID:27188386 | Myo1d | Rat | pirinixic acid | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MYO1D mRNA | CTD | PMID:19710929 | Myo1d | Rat | pirinixic acid | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | pirinixic acid results in increased expression of MYO1D mRNA | CTD | PMID:18301758 | Myo1d | Rat | pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of MYO1D mRNA | CTD | PMID:19483382 | Myo1d | Rat | profenofos | decreases expression | EXP | | 6480464 | profenofos results in decreased expression of MYO1D mRNA | CTD | PMID:17569032 | Myo1d | Rat | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of MYO1D mRNA | CTD | PMID:30047161 | Myo1d | Rat | SB 431542 | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Myo1d | Rat | silicon dioxide | decreases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of MYO1D mRNA | CTD | PMID:25895662 | Myo1d | Rat | silicon dioxide | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of MYO1D mRNA | CTD | PMID:29203145 | Myo1d | Rat | sodium arsenite | affects methylation | ISO | MYO1D (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of MYO1D gene | CTD | PMID:28589171 | Myo1d | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of MYO1D mRNA | CTD | PMID:30047161 | Myo1d | Rat | sulforaphane | multiple interactions | ISO | Myo1d (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of MYO1D mRNA | CTD | PMID:30529165 | Myo1d | Rat | testosterone | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of MYO1D mRNA | CTD | PMID:21592394 | Myo1d | Rat | testosterone | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Testosterone results in increased expression of MYO1D mRNA | CTD | PMID:21592394 | Myo1d | Rat | tetrachloromethane | affects expression | ISO | Myo1d (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of MYO1D mRNA | CTD | PMID:17484886 | Myo1d | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of MYO1D mRNA | CTD | PMID:31150632 | Myo1d | Rat | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of MYO1D protein | CTD | PMID:35544339 | Myo1d | Rat | thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of MYO1D mRNA | CTD | PMID:19483382 | Myo1d | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of MYO1D mRNA | CTD | PMID:34492290 | Myo1d | Rat | titanium dioxide | decreases methylation | ISO | Myo1d (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of MYO1D gene | CTD | PMID:35295148 | Myo1d | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MYO1D mRNA | CTD | PMID:25729387 | Myo1d | Rat | topotecan | affects response to substance | ISO | MYO1D (Homo sapiens) | 6480464 | MYO1D protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | Myo1d | Rat | triadimefon | increases expression | EXP | | 6480464 | triadimefon results in increased expression of MYO1D mRNA | CTD | PMID:30047161 | Myo1d | Rat | trichostatin A | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | trichostatin A results in increased expression of MYO1D mRNA | CTD | PMID:24935251 | Myo1d | Rat | triphenyl phosphate | affects expression | ISO | MYO1D (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of MYO1D mRNA | CTD | PMID:37042841 | Myo1d | Rat | triptonide | affects expression | ISO | Myo1d (Mus musculus) | 6480464 | triptonide affects the expression of MYO1D mRNA | CTD | PMID:33045310 | Myo1d | Rat | tunicamycin | increases expression | ISO | Myo1d (Mus musculus) | 6480464 | Tunicamycin results in increased expression of MYO1D mRNA | CTD | PMID:17127020 | Myo1d | Rat | tunicamycin | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of MYO1D mRNA | CTD | PMID:29453283 | Myo1d | Rat | urethane | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Urethane results in increased expression of MYO1D mRNA | CTD | PMID:28818685 | Myo1d | Rat | valproic acid | increases methylation | ISO | MYO1D (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of MYO1D gene | CTD | PMID:29154799 | Myo1d | Rat | valproic acid | multiple interactions | ISO | MYO1D (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYO1D mRNA | CTD | PMID:27188386 | Myo1d | Rat | valproic acid | increases expression | ISO | MYO1D (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MYO1D mRNA | CTD | PMID:19101580 more ... | Myo1d | Rat | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of MYO1D mRNA | CTD | PMID:23869203 | Myo1d | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of MYO1D mRNA | CTD | PMID:23034163 | |